2011
DOI: 10.5935/1984-6835.20110034
|View full text |Cite
|
Sign up to set email alerts
|

Alzheimer's Disease: Characterization, Evolution and Implications of the Neuroinflammatory Process

Abstract: Alzhei er's Disease: Characterizatio , Evolution and Implications of the Neuroinflammatory ProcessAbstract: álzhei e 'sàDiseaseà áD àisàaà eu odege e ativeàdisease characterized by a progressive memory loss and severe cognition decline, associated to degradation of cholinergic neurons in many areas of central nervous system (CNS), with a dramatic reduction in neurotransmitters, specially acetylcholine. The illness progression is also accompanied by behavior changes, leading to individual incapacity and depress… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 48 publications
(65 reference statements)
0
10
0
Order By: Relevance
“…Taking AD and PD as representative multifactorial diseases, despite these pathologies being distinct, they retain common characteristics such as a series of biochemical and physiological cascade events directly or indirectly associated with essential oxidative stress and inflammatory process. [95][96][97][99][100][101][102][106][107][108][109][110][111][112] Although the pharmaceutical industry aggressively markets anticholinergic drugs for the treatment of AD, these drugs have shown only marginal and transient effects, with no curative properties and only a moderate ability to restrain neurodegeneration progress. In spite of substantial investments made by the industry in search of new drugs, the truth is that progress toward innovative, small-molecule therapies for neurodegenerative diseases has been very modest.…”
Section: Where Are We Todaymentioning
confidence: 99%
See 2 more Smart Citations
“…Taking AD and PD as representative multifactorial diseases, despite these pathologies being distinct, they retain common characteristics such as a series of biochemical and physiological cascade events directly or indirectly associated with essential oxidative stress and inflammatory process. [95][96][97][99][100][101][102][106][107][108][109][110][111][112] Although the pharmaceutical industry aggressively markets anticholinergic drugs for the treatment of AD, these drugs have shown only marginal and transient effects, with no curative properties and only a moderate ability to restrain neurodegeneration progress. In spite of substantial investments made by the industry in search of new drugs, the truth is that progress toward innovative, small-molecule therapies for neurodegenerative diseases has been very modest.…”
Section: Where Are We Todaymentioning
confidence: 99%
“…In such pathologies, a multitude of physiological changes are present, including aberrant protein folding, protein degradation pathways, mitochondrial dysfunction, imbalanced energy production, compromised axonal transport processes, uncontrolled production of oxygen and nitrogen radical species, inflammation signaling, and ultimately induced cell death. 102,108,109,[118][119][120] In a non-physiological condition, abnormal accumulation senile plaques constituted by aggregates of toxic insoluble Aβ oligomers is due to an imbalance between the levels of Aβ production and clearance. Consequently, Aβ oligomers are overproduced and lead to synaptic damage by forming pore-like structures with channel activity, which can modify glutamate receptors and culminate in excitotoxicity.…”
Section: Where Are We Todaymentioning
confidence: 99%
See 1 more Smart Citation
“…Due to a not yet clearly understood dysfunction, enzymes such as βand γ-secretases can cleave the amyloid precursor protein (APP), generating Aβ 40 and Aβ 42 peptides that have a high aggregation capacity, producing insoluble protofibrils, responsible for the inflammatory process, among other pathological effects. Recent studies suggest that Aβ oligomers diffuse into the brain parenchyma and alter synaptic function, with selective neuronal loss in the cortex and hippocampus, regions characteristically affected in AD [5][6][7]. Among the mechanisms of neurotoxicity mediated by Aβ peptides, the formation of reactive oxygen species (ROS) and oxidative stress (OS) contribute to neuronal death.…”
Section: Introductionmentioning
confidence: 99%
“…Histopathological studies show senile plaques formed by fragments of insoluble β-amyloid peptide and intracellular neurofibrillary tangles, which may be formed by disruption of the microtubule cytoskeleton, due to hyperphosphorylation of TAU protein, accompanied by massive loss of neurons. [ 4 ]…”
Section: Introductionmentioning
confidence: 99%